Duntumumab

From Wikipedia, the free encyclopedia

This article does not cite any references or sources. (June 2007) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.

Duntumumab?
Therapeutic monoclonal antibody
Source	Human
Target	?
Identifiers
CAS number	?
ATC code	?
PubChem	?
Chemical data
Formula	?
Mol. mass	?
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Duntumumab is a human monoclonal antibody and which it is used to treat cancer.

v • d • e Human monoclonal antibodies ("-u-") "-limu-" (immune system) immunosuppression: Adalimumab, Atorolimumab, Gantenerumab, Golimumab, Lerdelimumab, Metelimumab, Morolimumab, Ziralimumab immune activation: Ipilimumab, Tremelimumab other: Bertilimumab "-kinu-" (interleukin as target) Canakinumab "-tumu-" (cancer immunotherapy) Adecatumumab, Anetumumab, Belimumab, Duntumumab, Iratumumab, Lexatumumab, Lucatumumab, Mapatumumab, Ofatumumab, Panitumumab, Pritumumab, Votumumab, Zalutumumab, Zanolimumab "-osu-" (bone) Denosumab "-mulu-" (musculoskeletal) Durimulumab, Durmulumab, Stamulumab "-fungu-" (fungal) Efungumab "-viru-" (viral) Exbivirumab, Libivirumab, Regavirumab, Sevirumab, Tuvirumab "-bacu-" (bacterial) Nebacumab, Raxibacumab